Patent Case Summaries | Week Ending April 11, 2025
By EsqSocial Corporation 17/04/25
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd., No. 2023-1977 (Fed. Cir. (D. Del.) Apr. 8, 2025). Opinion by Murphy (sitting by designation), joined by Moore and Chen. Azurity owns a patent directed to non-sterile drinkable liquid formulations and methods for using those formulations to treat a particular infection. After Alkem submitted an Abbreviated New Drug Application (ANDA) seeking approval of a generic formulation, Azurity filed an infringement lawsuit....
By: Alston & Bird